We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Whole Blood Rapid Test Aids Assessment of Concussion at Patient's Bedside

By HospiMedica International staff writers
Posted on 02 Apr 2024
Print article
Image: The i-STAT TBI cartridge has received FDA clearance to be used with whole blood (Photo courtesy of Abbott)
Image: The i-STAT TBI cartridge has received FDA clearance to be used with whole blood (Photo courtesy of Abbott)

In the United States annually, approximately five million individuals seek emergency department care for traumatic brain injuries (TBIs), yet over half of those suspecting a concussion may never get it checked. Traditional TBI assessments, including the Glasgow Coma Scale, subjective evaluations by physicians, and CT scans to identify brain damage, have largely remained unchanged for years. In the fast-paced environment of emergency departments, there is a critical need to triage patients quickly. Now, a novel test that uses whole blood to help assess patients with a suspected mild traumatic brain injury (mTBI), or concussion delivers lab-quality results in 15 minutes. This allows clinicians to conduct assessments at the patient’s bedside, extending its utility to urgent care centers and various other medical settings outside of the hospital emergency room.

Abbott’s (Abbott Park, IL, USA) i-STAT TBI cartridge has received clearance from the U.S. Food and Drug Administration (FDA) to be used with whole blood, enabling doctors to assess patients with suspected concussions directly at the bedside, and providing lab-quality results in 15 minutes. Unlike previous tests that required plasma or serum, necessitating laboratory processing, the new clearance allows for the implementation of the test in diverse medical environments, including urgent care clinics certified to perform moderate complexity tests. The clearance also marks a significant step towards enabling concussion assessments in non-traditional healthcare settings, such as sports events.

The i-STAT TBI cartridge with the i-STAT Alinity System involves the collection of a small venous blood sample for application to the test cartridge, which is then placed into the portable device. The test quantifies two brain-released biomarkers, ubiquitin C-terminal hydrolase L1 (UCH-L1) and glial fibrillary acidic protein (GFAP), which can signify potential brain injury. These biomarkers offer crucial insights shortly after an injury, aiding clinicians in devising an appropriate care strategy. This whole blood test on the i-STAT Alinity system provides a critical tool for clinicians to assess adults over 18 suspected of suffering from mTBI or concussion.

Results from this test can inform the decision against the need for a CT scan and help in deciding further steps in patient care. The flexibility to conduct the test using a whole blood sample enables its application in medical facilities lacking onsite labs, thus expediting the evaluation process for head injuries. With this clearance, the i-STAT TBI test becomes an important tool in evaluating patients up to 24 hours post-injury, addressing the common delay in seeking medical attention following an injury.

"Clinicians have needed an objective way to assess patients with concussions," said Beth McQuiston, M.D., medical director in Abbott's diagnostics business. "When you look at all the other diseases, or other organs in the body, they all have blood tests to help assess what's happening. Now, we have a whole blood test that can help assess the brain right at the patient's bedside – expanding access to more health providers and therefore patients."

Gold Member
12-Channel ECG
CM1200B
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Bronchoscope
EB-500

Print article

Channels

Critical Care

view channel
Image: The therapeutic tool can be used for children with kidney issues stemming from sepsis (Photo courtesy of 123RF)

New Device Treats Acute Kidney Injury from Sepsis

Sepsis, commonly referred to as "blood poisoning," can occur due to any infectious agent, triggering a systemic response by the body to combat the infection. This response involves the activation of circulating... Read more

Surgical Techniques

view channel
Image: The endoscopic device can 3D image the stiffness of individual biological cells and complex organisms (Photo courtesy of University of Nottingham)

World’s First Microscopic Probe to Revolutionize Early Cancer Diagnosis

In the early stages of cancer, the cells are significantly softer than normal cells, which facilitates their movement through small spaces and contributes to the rapid spread of the disease, a process... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.